The store will not work correctly when cookies are disabled.
1-[5-(4-Bromo-2-chlorophenyl)-2-furyl]-N-(4-piperidinylmethyl)methanamine dihydrochloride
ID: ALA4793916
PubChem CID: 17151695
Max Phase: Preclinical
Molecular Formula: C17H22BrCl3N2O
Molecular Weight: 383.72
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: Cl.Cl.Clc1cc(Br)ccc1-c1ccc(CNCC2CCNCC2)o1
Standard InChI: InChI=1S/C17H20BrClN2O.2ClH/c18-13-1-3-15(16(19)9-13)17-4-2-14(22-17)11-21-10-12-5-7-20-8-6-12;;/h1-4,9,12,20-21H,5-8,10-11H2;2*1H
Standard InChI Key: PKHDVCAJNNWLPS-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 24 0 0 0 0 0 0 0 0999 V2000
38.6763 -2.5671 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
44.6855 -3.3911 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.8660 -3.3859 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.4555 -4.0924 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.8594 -4.8047 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
44.6820 -4.8060 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
45.0929 -4.0989 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.6350 -4.0931 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.1540 -3.4254 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.3714 -3.6779 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.3670 -4.4993 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.1470 -4.7558 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
40.6993 -4.9762 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.9504 -4.6399 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
39.2826 -5.1168 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.5378 -4.7805 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.8701 -5.2615 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.4525 -3.9632 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.7077 -3.6270 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.0400 -4.1038 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
37.1212 -4.9211 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
45.9143 -4.1006 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
43.4616 -2.6717 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
39.0477 -6.5251 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
2 3 2 0
3 4 1 0
4 5 2 0
5 6 1 0
6 7 2 0
7 2 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 12 1 0
12 8 1 0
4 8 1 0
11 13 1 0
13 14 1 0
14 15 1 0
15 16 1 0
16 17 1 0
16 18 1 0
18 19 1 0
17 21 1 0
19 20 1 0
20 21 1 0
7 22 1 0
3 23 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 383.72 | Molecular Weight (Monoisotopic): 382.0448 | AlogP: 4.45 | #Rotatable Bonds: 5 |
Polar Surface Area: 37.20 | Molecular Species: BASE | HBA: 3 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 10.38 | CX LogP: 3.64 | CX LogD: -0.86 |
Aromatic Rings: 2 | Heavy Atoms: 22 | QED Weighted: 0.80 | Np Likeness Score: -1.05 |
References
1. Pereira GAN,da Silva EB,Braga SFP,Leite PG,Martins LC,Vieira RP,Soh WT,Villela FS,Costa FMR,Ray D,de Andrade SF,Brandstetter H,Oliveira RB,Caffrey CR,Machado FS,Ferreira RS. (2019) Discovery and characterization of trypanocidal cysteine protease inhibitors from the 'malaria box'., 179 [PMID:31284086] [10.1016/j.ejmech.2019.06.062] |